Literature DB >> 6585269

Suppression of cross-link formation in chloroethylnitrosourea-treated DNA by an activity in extracts of human leukemic lymphoblasts.

T P Brent.   

Abstract

Pulse treatment of DNA with any of several chloroethylnitrosoureas presently in clinical use leads to formation of monoadducts. Further incubation of these monoadducts in the absence of drug leads to DNA interstrand cross-links; however, this cross-link formation is suppressed by a partially purified extract of cultured human leukemic lymphoblasts. The cross-link-suppressing activity copurifies with O6-methylguanine-DNA methyltransferase, shows similar kinetics for heat inactivation, and shows similar responses to inhibitors. Reactions for both the cross-link-suppressing and methyltransferase activities reach completion within 5 min at 37 degrees, and both are stoichiometric rather than catalytic. These observations indicate that the number of cross-links induced by the chloroethylnitrosoureas and, hence, their cytotoxicity, should be inversely related to O6-methylguanine-DNA methyltransferase content of a cell.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6585269

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Evidence that covalent complex formation between BCNU-treated oligonucleotides and E. coli alkyltransferases requires the O6-alkylguanine function.

Authors:  P E Gonzaga; L Harris; G P Margison; T P Brent
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

2.  Affinity purification and characterization of human O6-alkylguanine-DNA alkyltransferase complexed with BCNU-treated, synthetic oligonucleotide.

Authors:  P E Gonzaga; T P Brent
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

Review 3.  Multifaceted roles of alkyltransferase and related proteins in DNA repair, DNA damage, resistance to chemotherapy, and research tools.

Authors:  Anthony E Pegg
Journal:  Chem Res Toxicol       Date:  2011-04-28       Impact factor: 3.739

4.  Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine.

Authors:  M E Dolan; G L Larkin; H F English; A E Pegg
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 5.  Drug resistance in brain tumors.

Authors:  L G Feun; N Savaraj; H J Landy
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  R B Mitchell; M E Dolan
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  O6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.

Authors:  T P Brent; P J Houghton; J A Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Sequential therapy with dacarbazine and carmustine: a phase I study.

Authors:  R B Mitchell; M E Dolan; L Janisch; N J Vogelzang; M J Ratain; R L Schilsky
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells.

Authors:  S L Gerson; K Miller; N A Berger
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

10.  Formation of covalent complexes between human O6-alkylguanine-DNA alkyltransferase and BCNU-treated defined length synthetic oligodeoxynucleotides.

Authors:  T P Brent; J S Remack
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.